Advertisement
Forex Nyheter
New Zealand Rate Decision Due On Wednesday
The Reserve Bank of New Zealand will wrap up its monetary policy meeting on Wednesday and then announce its decision on interest rates, highlighting a busy day for Asia-Pacific economic activity. The RBNZ is expected to hike its Official Cash Rate by 50 basis points, from 3.00 percent to 3.50 percent.
RTTNews |
1043 dagar sedan
TSX Ends On High Note Again
The Canadian market rallied sharply for a second straight day, as the mood remained upbeat on Tuesday amid rising hopes the Fed will be less aggressive with interest rate hikes after data on U.S. manufacturing activity, construction spending and job openings came in weaker than expected.
RTTNews
|
1043 dagar sedan
Dollar Continues To Drift Lower
The U.S. dollar tumbled and shed ground against its major counterparts on Tuesday, extending recent weakness, as weaker than expected economic data raised hopes the Fed will be less hawkish in its monetary policy stance at its upcoming meetings.
RTTNews
|
1043 dagar sedan
U.S. Stocks Close On Buoyant Note After Another Fine Performance
U.S. stocks climbed higher on Tuesday, rising sharply for a second straight session, amid hopes the Federal Reserve will slow down its aggression with regard to interest rate hikes after data showed a drop in job openings in the country.
RTTNews
|
1043 dagar sedan
U.S. Stocks Up Firmly In Positive Territory, Look Set To End On High Note
U.S. stocks are turning in a fine performance on Tuesday, extending gains from the previous session, on hopes the Federal Reserve will be less aggressive with rate hikes after data showed a weaker than expected pace of growth in U.S. manufacturing and construction sector activity.
RTTNews
|
1043 dagar sedan
Swiss Market Ends On Buoyant Note On Widespread Buying
The Switzerland stock market closed on a buoyant note on Tuesday, in line with markets across the globe, as fears about aggressive policy tightening by central banks faded a bit after weaker than expected U.S. manufacturing activity data.
RTTNews
|
1043 dagar sedan
European Stocks Close On Upbeat Note On All-round Buying
European markets closed on an upbeat note on Tuesday as stocks kept surging higher and higher after opening on a firm note, amid rising hopes the Fed and other major central banks will be less aggressive with regard to rate hikes in the coming months.
RTTNews
|
1043 dagar sedan
more news
Canadian Stocks Rising Sharply On Positive Global Cues
The Canadian market is high up in positive territory a little past noon on Tuesday, extending gains from the previous session, amid hopes the Fed will slow down its monetary tightening after data showed a slower pace of growth in the country's manufacturing activity in September.
RTTNews
|
1043 dagar sedan
Ford September Total U.S. Sales Down 8.9%
Ford Motor Co. (F) said Tuesday that total U.S. sales for the month of September 2022 decreased 8.9 percent to 142,644 vehicles from 156,614 vehicles in the same month last year. Ford's September retail sales were also down 11.7 percent.
RTTNews
|
1044 dagar sedan
Vinco Ventures Names Ross Miller As CEO And Gabe Hunterton As President
Vinco Ventures, Inc. (BBIG), a digital media and content technologies holding company, announced Tuesday that a settlement agreement was reached on September 28, 2022, in the Company's litigation in the State of Nevada.
RTTNews
|
1044 dagar sedan
American Electric Power Boosts FY22 Adj. EPS Outlook
Ahead of its analysts meeting in New York City later on Tuesday, electric utility American Electric Power Co., Inc. (AEP) raised its fiscal 2022 operating earnings guidance to a range of $4.97 to $5.07 from the prior forecast range of $4.87 to $5.07 per share.
RTTNews
|
1044 dagar sedan
Bay Street Looks Headed For Another Positive Start
Canadian shares are set to open on a firm note on Tuesday, extending gains from the previous session, as markets in Asia closed higher, and most of the markets across Europe are up sharply amid hopes global central banks will pause rate hikes during the later part of the year.
RTTNews
|
1044 dagar sedan
KalVista Pharma Terminates KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of HAE
KalVista Pharmaceuticals, Inc. (KALV) announced Monday that it has terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema (HAE).
RTTNews
|
1044 dagar sedan
Stay up to date!
Add Nyheter to your browser
Add To Chrome
